IndraLab
Statements
sparser
"Importantly, it has been shown recently in breast cancer cells that DUB3 can be phosphorylated by CYCLIN-dependent kinases 4 and 6 (CDK4/6) and this phosphorylation is essential for the deubiquitinase activity of DUB3 ( xref ), highlighting that DUB3 is a druggable target for cancer therapy."